Posts

Trump Imposes 100% Tariffs on Imported Patented Drugs with Key Exceptions

on

UK Agrees to Increase Drug Spending by 25% to Avoid US Pharma Tariffs

on

Japan Wins Exemption for Generics in US-Japan Trade Deal

on

Trump Locks in 15% Pharmaceutical Tariff Rate for EU, Generic Drugs Exempted

on

Pfizer's Bourla is 'cautiously optimistic' on tariffs, says M&A is on the table

on

Pfizer CEO Bourla suggests pharma tariffs will focus on US adversaries, not allies

on

U.S. Biotechs Reveal Tariff Exposure as Trade Inquiry Signals Imminent Pharmaceutical Tariffs

on

Trump Announces Imminent Major Tariffs on Pharmaceuticals: Implications for Global Markets and U.S. Manufacturing

on

Trump's Looming Pharmaceutical Tariffs: Uncertainty and Potential Impact

on

Indian Biomanufacturing Alliance: Boosting National Capabilities

on

Pfizer's European Manufacturing Vulnerable to Potential US Tariffs, CEO Warns

on

Illumina's Double-Edged Sword: Navigating US-China Trade Tensions

on

Pharmaceutical Industry Warns of Drug Shortages and Price Hikes Due to Trump's New Tariffs

on

Trump Imposes New Tariffs on Canada, Mexico, and China; Medical Industry Seeks Exemptions

on